Skip to content

Clinical trials

Completed Lung Diseases trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Not applicable Status: Completed Clear all

202 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20024
20035
20045
20052
20062
20072
20084
20098
20104
20115
20127
201311
20146
20158
20169
201710
201814
201919
202019
202112
20228
202314
202411
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed202

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Riphah International University6
Medipol University5
National Heart, Lung, and Blood Institute (NHLBI)5
Johns Hopkins University4
VA Office of Research and Development4
Assistance Publique - Hôpitaux de Paris3
Duke University3
NYU Langone Health3
National Taiwan University Hospital3
San Diego State University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases202
Pulmonary Disease, Chronic Obstructive38
Asthma23
Respiratory Tract Diseases16
Lung Neoplasms13
Cystic Fibrosis11
Heart Diseases11
Dyspnea10
Disease7
Neoplasms7

Trials

Showing 1 to 25 of 202. Each trial links to its page on Pharma Observatory.

102 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.